Evidence map›Paper›PMID 30621290›Full record

ArticleInternational journal of molecular sciences2019

LGM2605 Reduces Space Radiation-Induced NLRP3 Inflammasome Activation and Damage in In Vitro Lung Vascular Networks.

Shampa Chatterjee, Ralph A Pietrofesa, Kyewon Park, Jian-Qin Tao, Alejandro Carabe-Fernandez, Abigail T Berman, Constantinos Koumenis, Thais Sielecki, Melpo Christofidou-Solomidou

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  13. Article
  14. Review
  15. The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury.Frontiers in cell and developmental biology · 2020
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shampa ChatterjeeDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. shampac@pennmedicine.upenn.edu.
Ralph A PietrofesaDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. ralphp@pennmedicine.upenn.edu.
Kyewon ParkDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. kyewpark@pennmedicine.upenn.edu.
Jian-Qin TaoDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. taoj@pennmedicine.upenn.edu.
Alejandro Carabe-FernandezDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. a.carabe@pennmedicine.upenn.edu.
Abigail T BermanDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. abigail.berman@uphs.upenn.edu.
Constantinos KoumenisDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. koumenis@upenn.edu.
Thais SieleckiLignaMed LLC, Philadelphia, PA 19104, USA. thais.sielecki@lignamed.com.
Melpo Christofidou-SolomidouDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. melpo@pennmedicine.upenn.edu.

Funding

National Aeronautics and Space Administration NASA-Phase II 80NSSC18C0089National Aeronautics and Space Administration NASA-Phase I NNX17CL73PNational Institutes of Health 1P30 ES013508-02National Institutes of Health 1P42ES023720-01
6 · The paper itself

Abstract

Updated measurements of charged particle fluxes during the transit from Earth to Mars as well as on site measurements by Curiosity of Martian surface radiation fluxes identified potential health hazards associated with radiation exposure for human space missions. Designing mitigation strategies of radiation risks to astronauts is critical. We investigated radiation-induced endothelial cell damage and its mitigation by LGM2605, a radioprotector with antioxidant and free radical scavenging properties. We used an in vitro model of lung vascular networks (flow-adapted endothelial cells; FAECs), exposed to gamma rays, low/higher linear energy transfer (LET) protons (3⁻4 or 8⁻10 keV/µm, respectively), and mixed field radiation sources (gamma and protons), given at mission-relevant doses (0.25 gray (Gy)⁻1 Gy). We evaluated endothelial inflammatory phenotype, NLRP3 inflammasome activation, and oxidative cell injury. LGM2605 (100 µM) was added 30 min post radiation exposure and gene expression changes evaluated 24 h later. Radiation induced a robust increase in mRNA levels of antioxidant enzymes post 0.25 Gy and 0.5 Gy gamma radiation, which was significantly decreased by LGM2605. Intercellular cell adhesion molecule-1 (ICAM-1) and NOD-like receptor protein 3 (NLRP3) induction by individual or mixed-field exposures were also significantly blunted by LGM2605. We conclude that LGM2605 is a likely candidate to reduce tissue damage from space-relevant radiation exposure.

Indexed as

Gamma RaysAnimalsAntioxidantsButylene GlycolsGlucosidesHumansInflammasomesInflammationIntercellular Adhesion Molecule-1Linear Energy TransferLungNLR Family, Pyrin Domain-Containing 3 ProteinPhenotypeProtonsRadiation-Protective AgentsAntioxidantsButylene GlycolsGlucosidesInflammasomesIntercellular Adhesion Molecule-1LGM2605NLR Family, Pyrin Domain-Containing 3 ProteinProtonsRadiation-Protective Agentssecoisolariciresinol diglucosideantioxidantinflammasomeLGM2605lignanoxidative stressphase II enzymesreactive oxygen speciessecoisolariciresinol diglucosidespace radiation

Identifiers

PMID30621290
PMCPMC6337675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.